BioSpace News Archive

Medigene AG: Medigene participates at four conferences in November 2018

Medigene AG today announced its participation at the following upcoming investor and scientific conferences:

November 14, 2018
·
1 min read
Pharm Country

Shape-shifting robots perceive surroundings, make decisions for first time

General-purpose robots have plenty of limitations. They can be expensive and cumbersome. They often accomplish only a single type of task.

November 14, 2018
·
1 min read
Drug Development

Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF)

Galapagos NV reports first dosing in the PINTA Phase 2 trial with its GPR84 antagonist GLPG1205 in patients with idiopathic pulmonary fibrosis (IPF).

November 14, 2018
·
5 min read
Deals

Lonza Further Strengthens Focus on Its Healthcare Continuum Strategy by Signing Agreement to Divest Water Care Business to Platinum Equity

Lonza and Platinum Equity jointly announced today that Platinum Equity has entered into a definitive agreement with Lonza to acquire Lonza’s Water Care business and operations for USD 630 million.

November 14, 2018
·
7 min read
Novel antibacterial drugs developed at University of Eastern Finland

Researchers at the University of Eastern Finland have developed novel antibacterial compounds, focusing on the role of LsrK kinase. LsrK kinase is a protein involved in bacterial communication.

November 14, 2018
·
3 min read
Policy

ADNEC to host leading international events in November 2018

Abu Dhabi National Exhibitions Company (ADNEC) is set to host a series of leading international events in its venues in Abu Dhabi and Al Ain during November 2018, covering key economic sectors such as Oil & Gas, real-estate, Investment and healthcare.

November 14, 2018
·
4 min read
Drug Development

Aptinyx Completes Enrollment in Phase 2 Study of NYX-2925 for Painful Diabetic Peripheral Neuropathy

Top-line Data Expected Early in the First Quarter of 2019

November 14, 2018
·
5 min read
Business

Retrophin Reports Third Quarter 2018 Financial Results

Pivotal programs enrolling towards first data readout in 2019

November 14, 2018
·
17 min read
Genetown

Syndax Pharmaceuticals Announces Presentations at the 60th American Society of Hematology Annual Meeting

Syndax Pharmaceuticals, Inc. today announced that the Company’s Menin-MLLr program will be featured during two presentations at the 60th American Society of Hematology (ASH) Annual Meeting being held December 1-4, 2018 in San Diego, California.

November 14, 2018
·
4 min read
Business

TESARO Announces Third-Quarter 2018 Operating Results

ZEJULA® Q3 net sales totaled $63 million compared to $39 million for Q3 2017

November 14, 2018
·
12 min read